Charles Ellwood
Institute of Immunology(HR)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, T-cell and B-cell Immunology, SARS-CoV-2 and COVID-19 Research, DNA Repair Mechanisms, Immunotherapy and Immune Responses
Most-Cited Works
- → Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2(2013)62 cited
- → Mitigation of Acetylcholine Esterase Activity in the 1,7-Diazacarbazole Series of Inhibitors of Checkpoint Kinase 1(2015)18 cited
- → Boosting corrects a memory B cell defect in SARS-CoV-2 mRNA–vaccinated patients with inflammatory bowel disease(2022)5 cited
- → Notes(2011)
- → CHK1 kinase domain with diazacarbazole compound 19(2014)